Health & Environmental Research Online (HERO)


Print Feedback Export to File
508252 
Journal Article 
Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation 
Pal, M; Moffa, A; Sreekumar, A; Ethier, SP; Barder, TJ; Chinnaiyan, A; Lubman, DM 
2006 
Yes 
Analytical Chemistry
ISSN: 0003-2700
EISSN: 1520-6882 
78 
3 
702-710 
English 
A combination of protein microarrays and two-dimensional liquid-phase separation of proteins has been used for global profiling of the phosphoproteome in human breast cancer cells. This method has been applied to study changes in phosphorylation profile resulting from treatment of the cancer cells with PD173074, a known receptor tyrosine kinase inhibitor. The proteins separated by 2-D liquid-phase separation were arrayed on epoxy-coated glass slides and first screened for phosphorylation using fluorescent Pro-Q Diamond stain. The candidate proteins were then identified using MALDI/ESI MS/MS analysis. Further, validation was achieved by immunoblot analysis using anti-phosphotyrosine antibodies. A dynamic range of similar to 100 was achieved on the microarray when beta-casein was used as a standard protein for obtaining quantitative data. Importantly, the power of this method lies in its ability to identify a large group of proteins in a single experiment that are coregulated in their posttranslational modifications, upon treatment with the inhibitor. Since proteins are known to form interacting circuits that eventually lead to various signaling events, detection of such global phosphorylation profiles might enable delineation of functional pathways that play an important role during cancer initiation and progression. 
mass-spectrometry; posttranslational modifications; phosphorylated; proteins; tyrosine; growth; identification; receptor; technology; separation; overexpression